Second Line Therapy to Treat Age-related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself

NCT00457678 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Site did not enroll any patients to the study.

Conditions

Age Related Macular Degeneration

Interventions

DRUG: Visudyne
DRUG: Lucentis
DRUG: Dexamethasone

Sponsor

Vitreous -Retina- Macula Consultants of New York

Collaborators

[object Object]